Go to the profile of ValiSeek

ValiSeek

 
  • United Kingdom

About ValiSeek

ValiSeek Limited was formed as a Joint Venture single asset company in 2014 to progress cancer program VAL401 through early stage clinical trials to a stage attractive for out-licensing. ValiSeek is looking to initiate detailed licensing discussions prior to completion for co-development or out-licensing on a regional, global or disease specific basis to ensure a smooth continuation of their project VAL401.

Therapeutic Areas

Oncology

Technologies

Drug delivery Small molecules

Company Type

Biotechnology – Therapeutics

State of Ownership

Private

Topics

Topics contributed to:

Oncology

Editions participated in:

March 2017